2-(((2-(4-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-3-methoxyphenyl)thiazol-4-yl)methyl)amino)ethan-1-ol

ID: ALA4159911

PubChem CID: 145959114

Max Phase: Preclinical

Molecular Formula: C26H29ClN6O4S2

Molecular Weight: 589.14

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(-c2nc(CNCCO)cs2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1

Standard InChI:  InChI=1S/C26H29ClN6O4S2/c1-16(2)39(35,36)23-7-5-4-6-21(23)31-24-19(27)14-29-26(33-24)32-20-9-8-17(12-22(20)37-3)25-30-18(15-38-25)13-28-10-11-34/h4-9,12,14-16,28,34H,10-11,13H2,1-3H3,(H2,29,31,32,33)

Standard InChI Key:  SMZUNAOJRCYIBH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 42  0  0  0  0  0  0  0  0999 V2000
    9.2698   -3.9745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8653   -4.6844    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.6823   -4.6797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6335   -9.0664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8134   -9.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0395   -9.7791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4075   -8.3490    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5873   -8.3442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7605   -6.3896    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.0812   -6.8491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3083   -7.6372    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1280   -7.6647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4075   -6.8937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3096   -6.5699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2881   -5.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5674   -5.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8681   -5.7873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8895   -6.6071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6103   -6.9985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5459   -4.5388    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8251   -4.1475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1473   -5.3959    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4480   -5.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7272   -5.4331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0279   -5.8616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0494   -6.6815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7702   -7.0729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4695   -6.6443    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3071   -5.4703    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6078   -5.8988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8871   -5.5075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1878   -5.9360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2092   -6.7559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9300   -7.1473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6293   -6.7187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1691   -4.2570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4481   -4.6479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1911   -3.4371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3501   -7.1101    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  6  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
  9 13  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
 20 21  1  0
 16 20  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 23 28  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 30 35  2  0
 36 37  1  0
 36 38  1  0
  2 36  1  0
 31  2  1  0
 29 30  1  0
 25 29  1  0
 26 39  1  0
 22 23  1  0
 17 22  1  0
 10 14  1  0
  8 12  1  0
  7  8  1  0
  5  7  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4159911

    ---

Associated Targets(Human)

HCC78 (247 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 589.14Molecular Weight (Monoisotopic): 588.1380AlogP: 5.01#Rotatable Bonds: 12
Polar Surface Area: 138.36Molecular Species: NEUTRALHBA: 11HBD: 4
#RO5 Violations: 3HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.46CX Basic pKa: 7.53CX LogP: 4.20CX LogD: 3.83
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.17Np Likeness Score: -1.70

References

1. Wang Y, Chen S, Hu G, Wang J, Gou W, Zuo D, Gu Y, Gong P, Zhai X..  (2018)  Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.,  143  [PMID:29174809] [10.1016/j.ejmech.2017.11.008]

Source